Seval Ay Ersoy
Kartal Dr Lutfi Kırdar City Hospital, Türkiye
Kartal, 34865, Turkey
Kartal, 34865, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer: A Real-World Cohort Study.
Journal: Journal of clinical medicine
Published: January 06, 2026
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.
Journal: Journal of clinical medicine
Published: December 11, 2025
Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer.
Journal: Journal of clinical medicine
Published: December 05, 2025
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes.
Journal: Journal of clinical medicine
Published: December 04, 2025
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study.
Journal: Clinical Medicine Insights. Oncology
Published: October 09, 2025
The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study.
Journal: Medicina (Kaunas, Lithuania)
Published: August 31, 2025
Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage.
Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage.
Journal: Journal of clinical medicine
Published: August 18, 2025
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: April 11, 2025
Showing 1-8 of 8
Last Updated: 09/26/2026